Rein Therapeutics
RNTX
#10030
Rank
โ‚ฌ25.11 M
Marketcap
0,96ย โ‚ฌ
Share price
-1.74%
Change (1 day)
-57.37%
Change (1 year)

Earnings for Rein Therapeutics (RNTX)

Earnings in 2025 (TTM): -โ‚ฌ21.27 Million

According to Rein Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ23.77 Million a decrease over its 2023 earnings that were of -โ‚ฌ12.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rein Therapeutics from 2016 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ21.27 Million-10.54%
2024 -โ‚ฌ23.77 Million83.16%
2023 -โ‚ฌ12.98 Million-44.49%
2022 -โ‚ฌ23.38 Million3.92%
2021 -โ‚ฌ22.5 Million29.81%
2020 -โ‚ฌ17.33 Million-31.58%
2019 -โ‚ฌ25.33 Million-6.1%
2018 -โ‚ฌ26.98 Million38.66%
2017 -โ‚ฌ19.46 Million26.63%
2016 -โ‚ฌ15.37 Million